Otomycosis in Marrakech: Prospective Study of 19 Cases
International Journal of Infectious Diseases and Therapy
Volume 2, Issue 1, March 2017, Pages: 1-3
Received: Nov. 25, 2016; Accepted: Dec. 28, 2016; Published: Jan. 23, 2017
Views 2366      Downloads 73
Authors
El Mezouari El Mostafa, Department of Parasitology Mycology, Avicenna Military Hospital, Medical School, Cadi Ayyad University, Marrakech, Morocco
Mouhib H., Department of Parasitology Mycology, Avicenna Military Hospital, Medical School, Cadi Ayyad University, Marrakech, Morocco
Darouassi Y., Department of Otorhinolaryngoly, Avicenna Military Hospital, Medical School, Cadi Ayyad University, Marrakech, Morocco
Ammar H., Department of Otorhinolaryngoly, Avicenna Military Hospital, Medical School, Cadi Ayyad University, Marrakech, Morocco
Moutaj R., Department of Parasitology Mycology, Avicenna Military Hospital, Medical School, Cadi Ayyad University, Marrakech, Morocco
Article Tools
Follow on us
Abstract
Fungal otitis is an acute or subacute infection evolution, sometimes serious and rebellious to treatment. The objective of this work is to determine the prevalence of this infection in patients diagnosed at the laboratory of parasitology and mycology of the military hospital of Marrakech. A prospective study was performed that included patients with clinically suspected otomycosis. The ear removal is practiced during the otoscopic examination and diagnosis was confirmed by direct examination and culture. 19 cases of otomycosiswere diagnosed in 52 patients. Isolated fungal species were dominated by molds with a prevalence of 68.4% (N = 13) followed by the yeast with 31.6% (N = 6). It was not noted association of two fungal species. Aspergillusniger (35%), Aspergillusflavus (29%) and Candida albicans (13%) accounted for the most isolated fungal species. Otomycosis prevalence varies among studies. It is an infection that remains rebellious to treatment and whose management is difficult. It must be multi disciplinary combining mycological study as a diagnostic tool.
Keywords
Otomycosis, Aspergillus Flavus, Marrakech
To cite this article
El Mezouari El Mostafa, Mouhib H., Darouassi Y., Ammar H., Moutaj R., Otomycosis in Marrakech: Prospective Study of 19 Cases, International Journal of Infectious Diseases and Therapy. Vol. 2, No. 1, 2017, pp. 1-3. doi: 10.11648/j.ijidt.20170201.11
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
S. Aboulmakarim *, H. Tligui, M. El Mrini, I. Zakaria, N. Handour, A. Agoumi. Otomycoses: étude clinique et mycologique de 70 cas. J Mycol Med 2010;20: 48–52.
[2]
Nwabuisi C, Ologe FE. The fungal profile of otomycosis patients in Ilorin, Nigeria. Niger J Med 2001; 10: 124—6.
[3]
Rutt AL, Sataloff RT. Aspergillus otomycosis in an immunocompromised patient. ENT J 2008; 87 (II): 622-3.
[4]
K. D. Adoubryn, V. K. N’Gattia et al. Épidémiologie des otomycoses au centre hospitalier et universitaire de Yopougon (Abidjan-Côte d’Ivoire). J Mycol Med 2013 (Article in press).
[5]
PanktiPanchal, JayshreePethani, Dipti Patel, Sanjay Rathod, Parul Shah. Analysis of various fungal agents in clinically suspected cases of otomycosis. Indian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P. 865-869.
[6]
Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. Ear Nose Throat J 2000; 79: 60 p 6-9.
[7]
No authors listed; Estimated burden of acute otitis externa --- United States, 2003--2007. MMWR Morb Mortal WklyRep. 2011 May 20; 60 (19): 605-9.
[8]
Satish Het al; A Clinical Study of Otomycosis, IOSR Journal of Dental and Medical Sciences, 2279-0861. Volume 5, Issue 2 (Mar.-Apr. 2013).
[9]
Pontes ZB, Silva AD, Lima E, Guerra M, Oliviera N, Carvalho M, Guerra FS. Otomycosis: a retrospective study. Braz J Otorhinolaryngol 2009; 75: 3 p 67-70.
[10]
Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006; 135 (2): 787-91.
[11]
Yehia MM, Al-Habib HM, Shehab NM. Otomycosis: a common problem in North Iraq. J Laryngol Otol. 1990; 105 (5): 387-93.
[12]
Diener, U. L.; R. J. Cole; T. H. Sanders; G. A. Payne; L. S. Lee; M. A. Klich (1987). "Epidemiology of aflatoxin formation by Aspergillus flavus". Annual Review of Phytopathology. 25: 249–270.
[13]
Hedayati, M. T.; A. C. Pasqualotto; P. A. Warn; P. Bowyer; D. W. Denning (2007). "Aspergillus flavus: human pathogen, allergen, and mycotoxin producter". Microbiology (153): 1677–1692.
[14]
Kurnatowski P, Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses 2001; 44: 472—9.
[15]
B Barati, S A R Okhovvat, A Goljanian, M R Omrani. Otomycosis in Central Iran: A Clinical and Mycological Study, IRCMJ 2011 December; 13: 12 p 873-876.
[16]
Pratibha Dave, Mahendra Pal. Otomycosis due to Aspergillus flavus and Aspergillus niger in a flour mill worker. AMIR Journal. 2 (4): 7-9, 2015.
[17]
Gurr PA, Evans K, Dewey FM, Gurr SJ. Clin Otolaryngol Allied Sci. 1997 Jun; 22 (3): 275-83.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186